Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients.

作者: A. Ravaggi , C. Romani , B. Pasinetti , R. A. Tassi , E. Bignotti

DOI: 10.1007/S00705-006-0787-Y

关键词: VirologyImmune systemCarcinomaCervical cancerMedical microbiologyBiologyVaccinationSerologyVirusAntibody

摘要: Human papillomaviruses (HPVs), particularly HPV-16/18, are linked to cervical cancer development. Full-length, recombinant HPV-16/18 E7 oncoproteins were used in a new streptavidin-biotin capture ELISA method investigate anti-HPV antibody prevalence serum. Sera from 99 healthy women, 70 patients, and 30 patients with pre-invasive neoplasia analyzed. Anti-HPV-16/18 positivity was found 53% of 40% neoplasia, 8% women. Serum samples 12 obtained at different time intervals during the treatment. Eleven out showed correspondence between HPV-E7 levels (decreasing versus increasing) type response (clinically complete or partial progression stable disease) each serological evaluation. Five recurrent HPV-16/18-positive carcinoma analyzed before after vaccination E7-pulsed autologous dendritic cells; anti-HPV-16/18 3 5 In conclusion, this assay could potentially be as an adjunctive tool monitor treatment possibly detect induction vaccination, potential marker evaluate its efficacy.

参考文章(45)
Kim, Um, Hwang, Park, Kim, Namkoong, Park, The antibody response to HPV proteins and the genomic state of HPVs in patients with cervical cancer. International Journal of Gynecological Cancer. ,vol. 9, pp. 1- 11 ,(1999) , 10.1046/J.1525-1438.1999.09891.X
Alessandro D. Santin, Paul L. Hermonat, Antonella Ravaggi, Maurizio Chiriva-Internati, Dejin Zhan, Sergio Pecorelli, Groesbeck P. Parham, Martin J. Cannon, Induction of Human Papillomavirus-Specific CD4+ and CD8+ Lymphocytes by E7-Pulsed Autologous Dendritic Cells in Patients with Human Papillomavirus Type 16- and 18-Positive Cervical Cancer Journal of Virology. ,vol. 73, pp. 5402- 5410 ,(1999) , 10.1128/JVI.73.7.5402-5410.1999
Peter Sehr, Klaus Zumbach, Michael Pawlita, A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology Journal of Immunological Methods. ,vol. 253, pp. 153- 162 ,(2001) , 10.1016/S0022-1759(01)00376-3
Martin Moller, Raphael P. Viscidi, Yeping Sun, Eloisa Guerrero, Peter M. Hill, Farida Shah, F. Xavier Bosch, Nubia Muñoz, Lutz Gissmann, Keerti V. Shah, Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer. Virology. ,vol. 187, pp. 508- 514 ,(1992) , 10.1016/0042-6822(92)90453-V
Per Lenner, Joakim Dillner, Fredrik Wiklund, G�ran Hallmans, Ulf Stendahl, Serum antibody responses against human papillomavirus in relation to tumor characteristics, response to treatment, and survival in carcinoma of the uterine cervix. Cancer Immunology, Immunotherapy. ,vol. 40, pp. 201- 205 ,(1995) , 10.1007/BF01517352
Ricardo Rosales, Mario López-Contreras, Roberto Risco Cortes, Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: Correlation with presence of papillomavirus DNA Journal of Medical Virology. ,vol. 65, pp. 736- 744 ,(2001) , 10.1002/JMV.2098
Alessandro D. Santin, Stefania Bellone, Murat Gokden, Martin J. Cannon, Groesbeck P. Parham, Vaccination with HPV-18 E7–Pulsed Dendritic Cells in a Patient with Metastatic Cervical Cancer New England Journal of Medicine. ,vol. 346, pp. 1752- 1753 ,(2002) , 10.1056/NEJM200205303462219